{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:03:58Z","timestamp":1790240638157,"version":"4.1.0"},"reference-count":104,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Post-tuberculosis lung disease (PTLD) has only recently been put in the spotlight as a medical entity. Recent data suggest that up to 50% of tuberculosis (TB) patients are left with PTLD-related impairment after completion of TB treatment. The presence of residual cavities in the lung is the largest risk factor for the development of chronic pulmonary aspergillosis (CPA) globally. Diagnosis of CPA is based on four criteria including a typical radiological pattern, evidence of Aspergillus species, exclusion of alternative diagnosis, and a chronic course of disease. In this manuscript, we provide a narrative review on CPA as a serious complication for patients with PTLD.<\/jats:p>","DOI":"10.1055\/s-0043-1776913","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T03:40:20Z","timestamp":1704858020000},"page":"102-113","source":"Crossref","is-referenced-by-count":13,"title":["Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease"],"prefix":"10.1055","volume":"45","author":[{"given":"Matthias J.","family":"Neub\u00f6ck","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine 4 - Pneumology, Kepler University Hospital, Linz, Austria"},{"name":"Medical Faculty, Johannes Kepler University Linz, Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunar","family":"G\u00fcnther","sequence":"additional","affiliation":[{"name":"Department of Pulmonology and Allergology, Inselspital, Bern University Hospital, Bern, Switzerland"},{"name":"Department of Medical Sciences, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Barac","sequence":"additional","affiliation":[{"name":"Clinic for Infectious and Tropical Diseases, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper R.","family":"Davidsen","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Pulmonary Aspergillosis Centre Denmark, Odense University Hospital, Odense, Denmark"},{"name":"Department of Clinical Research, Odense Respiratory Research Unit, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian B.","family":"Laursen","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Pulmonary Aspergillosis Centre Denmark, Odense University Hospital, Odense, Denmark"},{"name":"Department of Clinical Research, Odense Respiratory Research Unit, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritesh","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inderpaul S.","family":"Sehgal","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Lange","sequence":"additional","affiliation":[{"name":"Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Hamburg-L\u00fcbeck-Borstel-Riems, Hamburg, Germany"},{"name":"Respiratory Medicine and International Health, University of L\u00fcbeck, L\u00fcbeck, Germany"},{"name":"Baylor College of Medicine and Texas Children's Hospital, Global Tuberculosis Program, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut J.F.","family":"Salzer","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine 4 - Pneumology, Kepler University Hospital, Linz, Austria"},{"name":"Medical Faculty, Johannes Kepler University Linz, Linz, Austria"},{"name":"Ignaz-Semmelweis-Institute, Interuniversity Institute for Infection Research, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for CPAnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"ref1","volume-title":"[Anonymous] Global tuberculosis report 2020","year":"2020"},{"issue":"08","key":"ref2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1159\/000512531","article-title":"Post-tuberculosis lung disease: clinical review of an under-recognised global challenge","volume":"100","author":"B W Allwood","year":"2021","journal-title":"Respiration"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"D W Denning","year":"2016","journal-title":"Eur Respir J"},{"issue":"03","key":"ref4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1183\/09031936.00226911","article-title":"Global burden of chronic pulmonary aspergillosis complicating sarcoidosis","volume":"41","author":"D W Denning","year":"2013","journal-title":"Eur Respir J"},{"issue":"03","key":"ref5","first-page":"6","article-title":"CPAnet registry-an international chronic pulmonary aspergillosis registry","volume":"6","author":"C B Laursen","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"07","key":"ref6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.5588\/ijtld.21.0034","article-title":"Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities","volume":"25","author":"J B Baluku","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"issue":"03","key":"ref7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1183\/13993003.00655-2019","article-title":"The global prevalence of latent tuberculosis: a systematic review and meta-analysis","volume":"54","author":"A Cohen","year":"2019","journal-title":"Eur Respir J"},{"issue":"04","key":"ref8","doi-asserted-by":"crossref","first-page":"e17601","DOI":"10.1371\/journal.pone.0017601","article-title":"Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review","volume":"6","author":"E W Tiemersma","year":"2011","journal-title":"PLoS One"},{"issue":"07","key":"ref9","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S1473-3099(20)30919-1","article-title":"Quantifying the global number of tuberculosis survivors: a modelling study","volume":"21","author":"P J Dodd","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"06","key":"ref10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.cmi.2023.02.013","article-title":"Long-term treatment outcomes in patients with multidrug-resistant tuberculosis","volume":"29","author":"C Maier","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"05","key":"ref11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1183\/13993003.00765-2022","article-title":"Long-term multidrug- and rifampicin-resistant tuberculosis treatment outcome by new WHO definitions in Germany","volume":"60","author":"R Otto-Knapp","year":"2022","journal-title":"Eur Respir J"},{"issue":"02","key":"ref12","first-page":"58","article-title":"World Health Organization treatment outcome definitions for tuberculosis: 2021 update","volume":"58","author":"N N Linh","year":"2021","journal-title":"Eur Respir J"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1473-3099(19)30309-3","article-title":"Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis","volume":"19","author":"K Romanowski","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"e1679","DOI":"10.1016\/S2214-109X(21)00367-3","article-title":"Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae","volume":"9","author":"N A Menzies","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2213-2600(20)30039-4","article-title":"Post-tuberculosis mortality and morbidity: valuing the hidden epidemic","volume":"8","author":"M Quaife","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"04","key":"ref16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5588\/ijtld.22.0514","article-title":"Post-TB health and wellbeing","volume":"27","author":"R Nightingale","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"issue":"07","key":"ref17","doi-asserted-by":"crossref","first-page":"e0159560","DOI":"10.1371\/journal.pone.0159560","article-title":"Effects of multidrug resistant tuberculosis treatment on patients' health related quality of life: results from a follow up study","volume":"11","author":"N Ahmad","year":"2016","journal-title":"PLoS One"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.4102\/sajp.v75i1.1319","article-title":"Post-tuberculosis health-related quality of life, lung function and exercise capacity in a cured pulmonary tuberculosis population in the Breede Valley District, South Africa","volume":"75","author":"K J Daniels","year":"2019","journal-title":"S Afr J Physiother"},{"issue":"08","key":"ref19","first-page":"887","article-title":"Evaluation of post-treatment health-related quality of life (HRQoL) among tuberculosis patients","volume":"11","author":"M Muniyandi","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"issue":"08","key":"ref20","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.socscimed.2004.08.024","article-title":"Perceptions of tuberculosis patients about their physical, mental and social well-being: a field report from south India","volume":"60","author":"R Rajeswari","year":"2005","journal-title":"Soc Sci Med"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/thoraxjnl-2020-215338","article-title":"The long term effect of pulmonary tuberculosis on income and employment in a low income, urban setting","volume":"76","author":"J Meghji","year":"2021","journal-title":"Thorax"},{"issue":"04","key":"ref22","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1016\/S1473-3099(23)00004-X","article-title":"Post-tuberculosis sequelae in children and adolescents: a systematic review","volume":"23","author":"V Igbokwe","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"846","DOI":"10.5588\/ijtld.21.0278","article-title":"The burden and determinants of post-TB lung disease","volume":"25","author":"S G Mpagama","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(21)00458-X","article-title":"Improving lung health in low-income and middle-income countries: from challenges to solutions","volume":"397","author":"J Meghji","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S1473-3099(19)30564-X","article-title":"The long shadow post-tuberculosis","volume":"19","author":"B Allwood","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"04","key":"ref26","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1183\/13993003.02325-2014","article-title":"Tuberculosis associates with both airflow obstruction and low lung function: BOLD results","volume":"46","author":"A F Amaral","year":"2015","journal-title":"Eur Respir J"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"e0000805","DOI":"10.1371\/journal.pgph.0000805","article-title":"Magnitude and factors associated with post-tuberculosis lung disease in low- and middle-income countries: a systematic review and meta-analysis","volume":"2","author":"E Maleche-Obimbo","year":"2022","journal-title":"PLoS Glob Public Health"},{"issue":"08","key":"ref28","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5588\/ijtld.20.0488","article-title":"Post-tuberculosis sequelae: the need to look beyond treatment outcome","volume":"24","author":"D Visca","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12890-018-0777-3","article-title":"TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB - a study protocol","volume":"19","author":"A Rachow","year":"2019","journal-title":"BMC Pulm Med"},{"issue":"147","key":"ref30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1183\/16000617.0077-2017","article-title":"Tuberculosis and lung damage: from epidemiology to pathophysiology","volume":"27","author":"S Ravimohan","year":"2018","journal-title":"Eur Respir Rev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijid.2014.12.016","article-title":"Tuberculosis and chronic respiratory disease: a systematic review","volume":"32","author":"A L Byrne","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"08","key":"ref32","doi-asserted-by":"crossref","first-page":"e0161176","DOI":"10.1371\/journal.pone.0161176","article-title":"A systematic review of the prevalence and pattern of imaging defined post-TB lung disease","volume":"11","author":"J Meghji","year":"2016","journal-title":"PLoS One"},{"issue":"06","key":"ref33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4103\/0970-2113.192871","article-title":"Correlation of chest computed tomography findings with dyspnea and lung functions in post-tubercular sequelae","volume":"33","author":"A Panda","year":"2016","journal-title":"Lung India"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nm.4177","article-title":"Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure","volume":"22","author":"S T Malherbe","year":"2016","journal-title":"Nat Med"},{"issue":"04","key":"ref35","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5588\/ijtld.20.0906","article-title":"Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function","volume":"25","author":"B W Allwood","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"issue":"06","key":"ref36","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1378\/chest.06-2949","article-title":"Pulmonary impairment after tuberculosis","volume":"131","author":"J G Pasipanodya","year":"2007","journal-title":"Chest"},{"issue":"168","key":"ref37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1183\/16000617.0221-2022","article-title":"Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14\u2009621 people","volume":"32","author":"O Ivanova","year":"2023","journal-title":"Eur Respir Rev"},{"issue":"16","key":"ref38","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/CM9.0000000000002771","article-title":"Post-tuberculosis lung disease and chronic obstructive pulmonary disease","volume":"136","author":"X Gai","year":"2023","journal-title":"Chin Med J (Engl)"},{"issue":"03","key":"ref39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/thoraxjnl-2019-213808","article-title":"Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study","volume":"75","author":"J Meghji","year":"2020","journal-title":"Thorax"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/thoraxjnl-2021-217190","article-title":"Respiratory symptoms and lung function in patients treated for pulmonary tuberculosis in Malawi: a prospective cohort study","volume":"77","author":"R Nightingale","year":"2022","journal-title":"Thorax"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/S0140-6736(22)00470-6","article-title":"Chronic obstructive pulmonary disease","volume":"399","author":"S A Christenson","year":"2022","journal-title":"Lancet"},{"issue":"03","key":"ref42","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/thoraxjnl-2021-218345","article-title":"Airflow obstruction and small airway dysfunction following pulmonary tuberculosis: a cross-sectional survey","volume":"78","author":"Z Xing","year":"2023","journal-title":"Thorax"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/thorax.55.1.32","article-title":"Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment","volume":"55","author":"E Hnizdo","year":"2000","journal-title":"Thorax"},{"issue":"06","key":"ref44","first-page":"767","article-title":"Residual lung damage after completion of treatment for multidrug-resistant tuberculosis","volume":"8","author":"S de Valli\u00e8re","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"ref45","doi-asserted-by":"crossref","first-page":"e80302","DOI":"10.1371\/journal.pone.0080302","article-title":"High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena","volume":"8","author":"A P Ralph","year":"2013","journal-title":"PLoS One"},{"issue":"03","key":"ref46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1183\/23120541.00026-2017","article-title":"Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis","volume":"3","author":"A L Byrne","year":"2017","journal-title":"ERJ Open Res"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12890-016-0213-5","article-title":"Lung functions among patients with pulmonary tuberculosis in Dar es Salaam - a cross-sectional study","volume":"16","author":"M Manji","year":"2016","journal-title":"BMC Pulm Med"},{"issue":"12","key":"ref48","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.5588\/ijtld.22.0091","article-title":"The household economic burden of drug-susceptible TB diagnosis and treatment in The Gambia","volume":"26","author":"I Devoid","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"issue":"03","key":"ref49","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5588\/ijtld.20.0824","article-title":"Clinical care for patients with post-TB lung disease","volume":"25","author":"G G\u00fcnther","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1186\/s12879-020-05515-4","article-title":"Risk factors for recurrent tuberculosis after successful treatment in a high burden setting: a cohort study","volume":"20","author":"P GT Cudahy","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"08","key":"ref51","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/cid\/civ1223","article-title":"Xpert MTB\/RIF results in patients with previous tuberculosis: can we distinguish true from false positive results?","volume":"62","author":"G Theron","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"19","key":"ref52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/jcm11195619","article-title":"Non-tuberculous mycobacteria and Aspergillus lung co-infection: systematic review","volume":"11","author":"M Fayos","year":"2022","journal-title":"J Clin Med"},{"issue":"02","key":"ref53","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/mmy\/myv093","article-title":"The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria","volume":"54","author":"K Takeda","year":"2016","journal-title":"Med Mycol"},{"issue":"01","key":"ref54","first-page":"S75","article-title":"Imaging of pulmonary post-tuberculosis sequelae","volume":"36","author":"R Khan","year":"2020","journal-title":"Pak J Med Sci"},{"issue":"04","key":"ref55","doi-asserted-by":"crossref","first-page":"e000745","DOI":"10.1136\/bmjgh-2018-000745","article-title":"International research and guidelines on post-tuberculosis chronic lung disorders: a systematic scoping review","volume":"3","author":"S C van Kampen","year":"2018","journal-title":"BMJ Glob Health"},{"issue":"08","key":"ref56","doi-asserted-by":"crossref","first-page":"e1008742","DOI":"10.1371\/journal.ppat.1008742","article-title":"Post-tuberculosis chronic pulmonary aspergillosis: an emerging public health concern","volume":"16","author":"F Bongomin","year":"2020","journal-title":"PLoS Pathog"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.ijid.2020.02.032","article-title":"Post tuberculosis treatment infectious complications","volume":"92S","author":"D Hsu","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"01","key":"ref58","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/jfmpc.jfmpc_846_22","article-title":"Prevalence of chronic pulmonary aspergillosis in fibrocavitary pulmonary tuberculosis patients","volume":"12","author":"R Rajpurohit","year":"2023","journal-title":"J Family Med Prim Care"},{"issue":"03","key":"ref59","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4103\/0970-2113.156233","article-title":"Evaluation of the radiological sequelae after treatment completion in new cases of pulmonary, pleural, and mediastinal tuberculosis","volume":"32","author":"B Menon","year":"2015","journal-title":"Lung India"},{"issue":"06","key":"ref60","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/resp.12574","article-title":"Aetiology and clinical characteristics of patients with bronchiectasis in a Chinese Han population: a prospective study","volume":"20","author":"Q Qi","year":"2015","journal-title":"Respirology"},{"issue":"09","key":"ref61","doi-asserted-by":"crossref","first-page":"e1269","DOI":"10.1016\/S2214-109X(19)30327-4","article-title":"Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry","volume":"7","author":"R Dhar","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"07","key":"ref62","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.rmed.2013.04.013","article-title":"Phenotyping adults with non-cystic fibrosis bronchiectasis: a prospective observational cohort study","volume":"107","author":"G A Anwar","year":"2013","journal-title":"Respir Med"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1164\/ajrccm.162.4.9906120","article-title":"An investigation into causative factors in patients with bronchiectasis","volume":"162","author":"M C Pasteur","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"S 03","key":"ref64","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1086\/376526","article-title":"Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review","volume":"37","author":"D W Denning","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1183\/13993003.01062-2016","article-title":"Predictors of mortality in chronic pulmonary aspergillosis","volume":"49","author":"D Lowes","year":"2017","journal-title":"Eur Respir J"},{"issue":"05","key":"ref66","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/myc.12075","article-title":"Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature","volume":"56","author":"R Agarwal","year":"2013","journal-title":"Mycoses"},{"issue":"04","key":"ref67","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1183\/09031936.00054810","article-title":"Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma","volume":"37","author":"N L Smith","year":"2011","journal-title":"Eur Respir J"},{"issue":"04","key":"ref68","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5588\/ijtld.20.0735","article-title":"Risk factors for chronic pulmonary aspergillosis in post-TB patients","volume":"25","author":"R Singla","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"issue":"07","key":"ref69","first-page":"7","article-title":"Chronic pulmonary aspergillosis situation among post tuberculosis patients in Vietnam: an observational study","volume":"7","author":"N TB Nguyen","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"01","key":"ref70","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13256-021-02721-9","article-title":"Misdiagnosis of chronic pulmonary aspergillosis as pulmonary tuberculosis at a tertiary care center in Uganda: a case series","volume":"15","author":"R Kwizera","year":"2021","journal-title":"J Med Case Rep"},{"issue":"12","key":"ref71","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2471\/BLT.11.089441","article-title":"Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis","volume":"89","author":"D W Denning","year":"2011","journal-title":"Bull World Health Organ"},{"issue":"12","key":"ref72","doi-asserted-by":"crossref","first-page":"e114745","DOI":"10.1371\/journal.pone.0114745","article-title":"Estimation of the burden of chronic and allergic pulmonary aspergillosis in India","volume":"9","author":"R Agarwal","year":"2014","journal-title":"PLoS One"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijregi.2022.11.005","article-title":"New estimation of the prevalence of chronic pulmonary aspergillosis (CPA) related to pulmonary TB - a revised burden for India","volume":"6","author":"D W Denning","year":"2022","journal-title":"IJID Reg"},{"issue":"01","key":"ref74","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12890-017-0500-9","article-title":"Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis","volume":"17","author":"R Kwizera","year":"2017","journal-title":"BMC Pulm Med"},{"issue":"09","key":"ref75","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.5588\/ijtld.17.0060","article-title":"Chronic pulmonary aspergillosis as a cause of smear-negative TB and\/or TB treatment failure in Nigerians","volume":"21","author":"R O Oladele","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"issue":"09","key":"ref76","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s10096-015-2409-7","article-title":"Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran","volume":"34","author":"M T Hedayati","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"02","key":"ref77","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/myc.12589","article-title":"Characterization of patients with chronic pulmonary aspergillosis according to the new ESCMID\/ERS\/ECMM and IDSA guidelines","volume":"60","author":"H J Salzer","year":"2017","journal-title":"Mycoses"},{"issue":"07","key":"ref78","doi-asserted-by":"crossref","first-page":"519","DOI":"10.5588\/ijtld.21.0185","article-title":"Chronic pulmonary aspergillosis as a sequel to pulmonary TB","volume":"25","author":"H JF Salzer","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"ref79","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.7196\/SAMJ.2021.v111i11.15711","article-title":"Respiratory presentations to acute services at a tertiary hospital in South Africa","volume":"111","author":"V Ngah","year":"2021","journal-title":"S Afr Med J"},{"issue":"07","key":"ref80","doi-asserted-by":"crossref","first-page":"e0011284","DOI":"10.1371\/journal.pntd.0011284","article-title":"Prevalence and predictors of Aspergillus seropositivity and chronic pulmonary aspergillosis in an urban tertiary hospital in Sierra Leone: a cross-sectional study","volume":"17","author":"S Lakoh","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"04","key":"ref81","first-page":"7","article-title":"Performance of LDBio Aspergillus WB and ICT antibody detection in chronic pulmonary aspergillosis","volume":"7","author":"A Rozaliyani","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"01","key":"ref82","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1186\/s12879-022-07782-9","article-title":"Serological evidence of chronic pulmonary aspergillosis in tuberculosis patients in Kenya","volume":"22","author":"A Mohamed","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"03","key":"ref83","doi-asserted-by":"crossref","first-page":"115124","DOI":"10.1016\/j.diagmicrobio.2020.115124","article-title":"Evaluation and comparison of automated and manual ELISA for diagnosis of chronic pulmonary aspergillosis (CPA) in Indonesia","volume":"98","author":"F Setianingrum","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"04","key":"ref84","first-page":"6","article-title":"Chronic pulmonary aspergillosis in post tuberculosis patients in Indonesia and the role of LDBio Aspergillus ICT as part of the diagnosis scheme","volume":"6","author":"A Rozaliyani","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"02","key":"ref85","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1183\/13993003.03345-2020","article-title":"Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis","volume":"58","author":"T Maitre","year":"2021","journal-title":"Eur Respir J"},{"issue":"02","key":"ref86","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jac\/dkx390","article-title":"A CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention","volume":"73","author":"C Godet","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"08","key":"ref87","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3201\/eid2408.171312","article-title":"Case definition of chronic pulmonary aspergillosis in resource-constrained settings","volume":"24","author":"D W Denning","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"42","key":"ref88","doi-asserted-by":"crossref","first-page":"e8315","DOI":"10.1097\/MD.0000000000008315","article-title":"Clinical features and diagnosis of chronic pulmonary aspergillosis in Chinese patients","volume":"96","author":"X Hou","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"ref89","first-page":"1150","article-title":"[Aspergillus in airway material : ignore or treat?]","volume":"58","author":"H JF Salzer","year":"2017","journal-title":"Internist (Berl)"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3389\/fmicb.2018.02223","article-title":"Evaluation of galactomannan testing, the Aspergillus-specific lateral-flow device test and levels of cytokines in bronchoalveolar lavage fluid for diagnosis of chronic pulmonary aspergillosis","volume":"9","author":"H JF Salzer","year":"2018","journal-title":"Front Microbiol"},{"issue":"01","key":"ref91","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.diagmicrobio.2018.01.001","article-title":"Receiver operating characteristic curve analysis of four Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis","volume":"91","author":"I D Page","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10","key":"ref93","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/myc.12815","article-title":"Diagnostic cut-off of Aspergillus fumigatus-specific IgG in the diagnosis of chronic pulmonary aspergillosis","volume":"61","author":"I S Sehgal","year":"2018","journal-title":"Mycoses"},{"issue":"03","key":"ref94","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"E Polverino","year":"2017","journal-title":"Eur Respir J"},{"issue":"02","key":"ref95","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1183\/13993003.02520-2016","article-title":"Awareness of predictors of mortality may help improve outcome in chronic pulmonary aspergillosis","volume":"49","author":"H J Salzer","year":"2017","journal-title":"Eur Respir J"},{"issue":"06","key":"ref96","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jiac.2014.02.003","article-title":"Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance treatment by antifungal triazoles","volume":"20","author":"K Koyama","year":"2014","journal-title":"J Infect Chemother"},{"issue":"02","key":"ref97","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijantimicag.2018.06.001","article-title":"Assessment of posaconazole salvage therapy in chronic pulmonary aspergillosis using predefined response criteria","volume":"52","author":"I Rodriguez-Goncer","year":"2018","journal-title":"Int J Antimicrob Agents"},{"issue":"07","key":"ref98","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/17476348.2020.1750956","article-title":"An overview of the available treatments for chronic cavitary pulmonary aspergillosis","volume":"14","author":"I S Sehgal","year":"2020","journal-title":"Expert Rev Respir Med"},{"issue":"07","key":"ref99","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S1473-3099(22)00057-3","article-title":"Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India","volume":"22","author":"I S Sehgal","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"06","key":"ref100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1183\/13993003.02950-2021","article-title":"Treatment outcome definitions in chronic pulmonary aspergillosis: a CPAnet consensus statement","volume":"59","author":"E Van Braeckel","year":"2022","journal-title":"Eur Respir J"},{"issue":"02","key":"ref101","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000489474","article-title":"Treatment of chronic pulmonary aspergillosis: current standards and future perspectives","volume":"96","author":"A Alastruey-Izquierdo","year":"2018","journal-title":"Respiration"},{"issue":"04","key":"ref102","doi-asserted-by":"crossref","first-page":"e0193732","DOI":"10.1371\/journal.pone.0193732","article-title":"Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis","volume":"13","author":"F Bongomin","year":"2018","journal-title":"PLoS One"},{"issue":"04","key":"ref103","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/infdis\/jiab428","article-title":"inhaled corticosteroids increase risk of nontuberculous mycobacterial lung disease: a nested case-control study and meta-analysis","volume":"225","author":"C C Shu","year":"2022","journal-title":"J Infect Dis"},{"issue":"05","key":"ref104","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1590\/S1806-37562016000000226","article-title":"Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?","volume":"42","author":"M Mu\u00f1oz-Torrico","year":"2016","journal-title":"J Bras Pneumol"},{"issue":"12","key":"ref105","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/ntr\/ntab117","article-title":"How do smoking status and smoking cessation efforts affect TB recurrence after successful completion of anti-TB treatment? A multicenter, prospective cohort study with a 7-year follow-up in China","volume":"23","author":"H Lin","year":"2021","journal-title":"Nicotine Tob Res"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1776913.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T17:20:39Z","timestamp":1730827239000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1776913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":104,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2024,1,29]]},"published-print":{"date-parts":[[2024,2]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1776913","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]}}}